Zoledronic acid
0,8 mg/ml, 5 ml № 1, № 5, № 10
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Concentrate for solution for infusion
ATC code
М05ВА08
RX/OTC
RX
Registration certificate
UA/16730/01/01
General properties
Pharmacotherapeutic group
Means affecting the structure and mineralization of bones. Bisphosphonates.
Therapeutic indications
- Prevention of symptoms associated with damage to the bone tissue (pathological fractures, compression of the spinal trunk, complications after surgical interventions and radiation therapy, or hypercalcemia caused by a malignant tumor) in patients with malignant tumors in the later stages.
- Treatment of hypercalcemia caused by a malignant tumor.
Contraindications
Hypersensitivity to the active ingredient (Zoledronic acid), other bisphosphonates, or any excipients in the drug composition.
Pregnancy and lactation.
Pharmaceutical characteristics
Main physicochemical properties
Transparent colorless liquid.
Shelf life
2 years.
Storage
Store in original packaging at a temperature not higher than 25 °C. Keep out of the reach of children.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
